206 related articles for article (PubMed ID: 17699321)
1. Incidence of ANCA-associated primary renal vasculitis in the Miyazaki Prefecture: the first population-based, retrospective, epidemiologic survey in Japan.
Fujimoto S; Uezono S; Hisanaga S; Fukudome K; Kobayashi S; Suzuki K; Hashimoto H; Nakao H; Nunoi H
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1016-22. PubMed ID: 17699321
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K.
Fujimoto S; Watts RA; Kobayashi S; Suzuki K; Jayne DR; Scott DG; Hashimoto H; Nunoi H
Rheumatology (Oxford); 2011 Oct; 50(10):1916-20. PubMed ID: 21798892
[TBL] [Abstract][Full Text] [Related]
3. Renal vasculitis in Japan and the UK--are there differences in epidemiology and clinical phenotype?
Watts RA; Scott DG; Jayne DR; Ito-Ihara T; Muso E; Fujimoto S; Harabuchi Y; Kobayashi S; Suzuki K; Hashimoto H
Nephrol Dial Transplant; 2008 Dec; 23(12):3928-31. PubMed ID: 18565978
[TBL] [Abstract][Full Text] [Related]
4. Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies.
Tidman M; Olander R; Svalander C; Danielsson D
J Intern Med; 1998 Aug; 244(2):133-41. PubMed ID: 10095799
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies available in Japan and Europe.
Ito-Ihara T; Muso E; Kobayashi S; Uno K; Tamura N; Yamanishi Y; Fukatsu A; Watts RA; Scott DG; Jayne DR; Suzuki K; Hashimoto H
Clin Exp Rheumatol; 2008; 26(6):1027-33. PubMed ID: 19210866
[TBL] [Abstract][Full Text] [Related]
6. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
[TBL] [Abstract][Full Text] [Related]
7. Clinicoepidemiological manifestations of RPGN and ANCA-associated vasculitides: an 11-year retrospective hospital-based study in Japan.
Suzuki Y; Takeda Y; Sato D; Kanaguchi Y; Tanaka Y; Kobayashi S; Suzuki K; Hashimoto H; Ozaki S; Horikoshi S; Tomino Y
Mod Rheumatol; 2010 Feb; 20(1):54-62. PubMed ID: 19821007
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
[TBL] [Abstract][Full Text] [Related]
9. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
Ozaki S
Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
[TBL] [Abstract][Full Text] [Related]
10. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
Csernok E; Ahlquist D; Ullrich S; Gross WL
Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
[TBL] [Abstract][Full Text] [Related]
11. [Pathogenesis of primary systemic vasculitides (I): ANCA-positive vasculitides].
Guilpain P; Chanseaud Y; Tamby MC; Mahr A; Servettaz A; Guillevin L; Mouthon L
Presse Med; 2005 Aug; 34(14):1013-22. PubMed ID: 16225257
[TBL] [Abstract][Full Text] [Related]
12. Necrotizing vasculitis in Greece: clinical, immunological and immunogenetic aspects. A study of 66 patients.
Boki KA; Dafni U; Karpouzas GA; Papasteriades C; Drosos AA; Moutsopoulos HM
Br J Rheumatol; 1997 Oct; 36(10):1059-66. PubMed ID: 9374922
[TBL] [Abstract][Full Text] [Related]
13. Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis.
Fienberg R; Mark EJ; Goodman M; McCluskey RT; Niles JL
Hum Pathol; 1993 Feb; 24(2):160-8. PubMed ID: 8381764
[TBL] [Abstract][Full Text] [Related]
14. The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study.
Berti A; Cornec D; Crowson CS; Specks U; Matteson EL
Arthritis Rheumatol; 2017 Dec; 69(12):2338-2350. PubMed ID: 28881446
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies.
Chen M; Yu F; Zhang Y; Zou WZ; Zhao MH; Wang HY
Kidney Int; 2005 Nov; 68(5):2225-9. PubMed ID: 16221222
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of PR3-ANCA associated vasculitis.
Kallenberg CG
J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
[TBL] [Abstract][Full Text] [Related]
17. Incidence and disease associations of a proteinase 3-antineutrophil cytoplasmic antibody idiotype (5/7 Id) whose antiidiotype inhibits proteinase 3-antineutrophil cytoplasmic antibody antigen binding activity.
Strunz HP; Csernok E; Gross WL
Arthritis Rheum; 1997 Jan; 40(1):135-42. PubMed ID: 9008609
[TBL] [Abstract][Full Text] [Related]
18. ANCA Glomerulonephritis and Vasculitis.
Jennette JC; Nachman PH
Clin J Am Soc Nephrol; 2017 Oct; 12(10):1680-1691. PubMed ID: 28842398
[TBL] [Abstract][Full Text] [Related]
19. Anti-neutrophil cytoplasmic antibody-associated vasculitis, large vessel vasculitis and Kawasaki disease in Japan.
Kobayashi S; Fujimoto S; Takahashi K; Suzuki K
Kidney Blood Press Res; 2010; 33(6):442-55. PubMed ID: 21071954
[TBL] [Abstract][Full Text] [Related]
20. ANCA-associated vasculitis with renal involvement: an outcome analysis.
Weidner S; Geuss S; Hafezi-Rachti S; Wonka A; Rupprecht HD
Nephrol Dial Transplant; 2004 Jun; 19(6):1403-11. PubMed ID: 15069175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
